JEAN BINKLEY: Open Payments
NPI 1598933129 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 22 payments from 7 companies in 2025. Trend: 2023 $159 · 2024 $1,080 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $236 |
| Astellas Pharma US Inc | 3 | $159 |
| ABBVIE INC. | 9 | $156 |
| AstraZeneca Pharmaceuticals LP | 2 | $76 |
| PFIZER INC. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: FREESTYLE LIBRE 3, Veozah, QULIPTA, AIRSUPRA, NURTEC ODT, UBRELVY, KEVEYIS, TRELEGY ELLIPTA.
Industry payments across DE — which companies pay providers there.
